Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes

Objective. We aimed to evaluate whether the reduction in serum high-sensitivity C-reactive protein (hs-CRP) favors kidney outcomes. Methods. This study was a subanalysis including patients with impaired fasting glucose or diabetes of the Kailuan cohort study. The predictor was based on two consecuti...

Full description

Saved in:
Bibliographic Details
Main Authors: Lili Liu, Bixia Gao, Jinwei Wang, Chao Yang, Shouling Wu, Yuntao Wu, Shuohua Chen, Qiuyun Li, Huifen Zhang, Guodong Wang, Min Chen, Ming-hui Zhao, Luxia Zhang
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/2720905
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850218239530893312
author Lili Liu
Bixia Gao
Jinwei Wang
Chao Yang
Shouling Wu
Yuntao Wu
Shuohua Chen
Qiuyun Li
Huifen Zhang
Guodong Wang
Min Chen
Ming-hui Zhao
Luxia Zhang
author_facet Lili Liu
Bixia Gao
Jinwei Wang
Chao Yang
Shouling Wu
Yuntao Wu
Shuohua Chen
Qiuyun Li
Huifen Zhang
Guodong Wang
Min Chen
Ming-hui Zhao
Luxia Zhang
author_sort Lili Liu
collection DOAJ
description Objective. We aimed to evaluate whether the reduction in serum high-sensitivity C-reactive protein (hs-CRP) favors kidney outcomes. Methods. This study was a subanalysis including patients with impaired fasting glucose or diabetes of the Kailuan cohort study. The predictor was based on two consecutive visits of hs-CRP levels in 2006 and 2008. A total of 3924 patients with hs-CRP≥3 mg/L in 2006 were divided into two groups according to whether the levels of hs-CRP were reduced in 2008: Group 1: no reduction: hs-CRP≥3 mg/L in 2008; Group 2: reduction: hs-CRP<3 mg/L in 2008. Kidney outcomes include kidney function decline and development and progression of proteinuria and were followed up until the end of 2015. Results. There were 3905, 2049, and 493 patients included into our analysis for the outcomes of kidney function decline and the development and progression of proteinuria, respectively. A total of 398, 297, and 47 events occurred after 5 years of follow-up, respectively. Cox regression revealed that patients with reduction in hs-CRP have lower risk of kidney function decline (HR 0.71, 95% CI 0.57-0.89, and P=0.002) and development of proteinuria (0.77, 0.61-0.99, and P=0.038) after controlling for potential confounders as compared to those with no reduction in hs-CRP levels. Conclusions. Reduction in serum hs-CRP levels favors kidney outcomes in patients with impaired fasting glucose or diabetes.
format Article
id doaj-art-3dd6ca7a4aac4fdcafe0b8dc348c9f74
institution OA Journals
issn 2314-6745
2314-6753
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-3dd6ca7a4aac4fdcafe0b8dc348c9f742025-08-20T02:07:49ZengWileyJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/27209052720905Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or DiabetesLili Liu0Bixia Gao1Jinwei Wang2Chao Yang3Shouling Wu4Yuntao Wu5Shuohua Chen6Qiuyun Li7Huifen Zhang8Guodong Wang9Min Chen10Ming-hui Zhao11Luxia Zhang12Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, ChinaDepartment of Cardiology, Kailuan General Hospital, Tangshan 063001, ChinaDepartment of Cardiology, Kailuan General Hospital, Tangshan 063001, ChinaDepartment of Health Care Center, Kailuan General Hospital, Tangshan 063001, ChinaDepartment of Endocrinology, Kailuan General Hospital, Tangshan 063001, ChinaDepartment of Laboratory, Kailuan General Hospital, Tangshan 063001, ChinaDepartment of Cardiology, Kailuan General Hospital, Tangshan 063001, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, ChinaRenal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing 100034, ChinaObjective. We aimed to evaluate whether the reduction in serum high-sensitivity C-reactive protein (hs-CRP) favors kidney outcomes. Methods. This study was a subanalysis including patients with impaired fasting glucose or diabetes of the Kailuan cohort study. The predictor was based on two consecutive visits of hs-CRP levels in 2006 and 2008. A total of 3924 patients with hs-CRP≥3 mg/L in 2006 were divided into two groups according to whether the levels of hs-CRP were reduced in 2008: Group 1: no reduction: hs-CRP≥3 mg/L in 2008; Group 2: reduction: hs-CRP<3 mg/L in 2008. Kidney outcomes include kidney function decline and development and progression of proteinuria and were followed up until the end of 2015. Results. There were 3905, 2049, and 493 patients included into our analysis for the outcomes of kidney function decline and the development and progression of proteinuria, respectively. A total of 398, 297, and 47 events occurred after 5 years of follow-up, respectively. Cox regression revealed that patients with reduction in hs-CRP have lower risk of kidney function decline (HR 0.71, 95% CI 0.57-0.89, and P=0.002) and development of proteinuria (0.77, 0.61-0.99, and P=0.038) after controlling for potential confounders as compared to those with no reduction in hs-CRP levels. Conclusions. Reduction in serum hs-CRP levels favors kidney outcomes in patients with impaired fasting glucose or diabetes.http://dx.doi.org/10.1155/2020/2720905
spellingShingle Lili Liu
Bixia Gao
Jinwei Wang
Chao Yang
Shouling Wu
Yuntao Wu
Shuohua Chen
Qiuyun Li
Huifen Zhang
Guodong Wang
Min Chen
Ming-hui Zhao
Luxia Zhang
Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
Journal of Diabetes Research
title Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
title_full Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
title_fullStr Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
title_full_unstemmed Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
title_short Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
title_sort reduction in serum high sensitivity c reactive protein favors kidney outcomes in patients with impaired fasting glucose or diabetes
url http://dx.doi.org/10.1155/2020/2720905
work_keys_str_mv AT lililiu reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT bixiagao reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT jinweiwang reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT chaoyang reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT shoulingwu reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT yuntaowu reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT shuohuachen reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT qiuyunli reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT huifenzhang reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT guodongwang reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT minchen reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT minghuizhao reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes
AT luxiazhang reductioninserumhighsensitivitycreactiveproteinfavorskidneyoutcomesinpatientswithimpairedfastingglucoseordiabetes